Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Explore clinical trials studying Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Study availability and eligibility vary by location and protocol.

22 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma trial results

Completed

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

NCT04116437

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +29 more
Locations
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
  • Christiana Care Newark, Delaware, United States
  • Scri Florida Cancer Specialists South Fort Myers, Florida, United States
  • St Century Oncology Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

NCT02268851

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • St. Francis Hospital and Cancer Center Hartford, Connecticut, United States
  • Eastern Maine Medical Center/ Northern Light Cancer Care Brewer, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00090090

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations
  • Alta Bates Cancer Center Berkeley, California, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Tower Hematology Oncology Medical Group Los Angeles, California, United States
View Trial Details

Related conditions